Lam Hio-Wa, Lin Hui-Chao, Lao Sin-Cheng, Gao Jian-Li, Hong Si-Jia, Leong Chi-Weng, Yue Patrick Ying-Kit, Kwan Yiu-Wa, Leung Anskar Yu-Hung, Wang Yi-Tao, Lee Simon Ming-Yuen
Institute of Chinese Medical Sciences, University of Macau, Av. Padre Tomás Pereira S.J., Taipa, Macao, China.
J Cell Biochem. 2008 Jan 1;103(1):195-211. doi: 10.1002/jcb.21403.
Angiogenesis plays an important role in a wide range of physiological processes such as wound healing and fetal development. Many diseases are associated with imbalances in regulation of angiogenesis, in which it is either excessive or there is insufficient blood vessel formation. Angelica sinensis (AS), commonly used in the prescriptions of Chinese medicine, is a potential candidate for curing such diseases. However, biological effects of AS on angiogenesis and underlying mechanisms are yet to be fully elucidated. This investigation describes the angiogenic effects of AS extract on human endothelial cells (HUVEC) in vitro and zebrafish in vivo. The extract was demonstrated, by XTT assay and microscopic cell counting, to stimulate the proliferation of HUVEC; in addition, flow cytometry analysis indicated that the extract increased the percentage of HUVEC in the S phase. The wound healing migration assay illustrated that a dramatic increase in migration could be measured in AS extract-treated HUVEC. Meanwhile, the number of invaded cells and the mean tube length were significantly increased in AS extract treatment groups. The extract was also demonstrated to promote changes in subintestinal vessels (SIVs) in zebrafish, one feature of angiogenesis. In addition, AS extract was found by real-time PCR to enhance vascular endothelial growth factor (VEGF) mRNA expression. In a bead-based immunoassay, higher levels of p38 and JNK 1/2 expression were also observed in effusions compared with control cells. All results suggest that Angelica sinensis extract can promote angiogenesis, and that the angiogenic effects involve p38 and JNK 1/2 phosphorylation.
血管生成在多种生理过程中发挥着重要作用,如伤口愈合和胎儿发育。许多疾病都与血管生成调节失衡有关,即血管生成要么过度,要么血管形成不足。中药方剂中常用的当归是治疗此类疾病的潜在候选药物。然而,当归对血管生成的生物学效应及其潜在机制尚未完全阐明。本研究描述了当归提取物在体外对人脐静脉内皮细胞(HUVEC)和在体内对斑马鱼的血管生成作用。通过XTT法和显微镜细胞计数证明,该提取物能刺激HUVEC的增殖;此外,流式细胞术分析表明,该提取物增加了处于S期的HUVEC的百分比。伤口愈合迁移试验表明,经当归提取物处理的HUVEC的迁移能力显著增强。同时,当归提取物处理组的侵袭细胞数量和平均管长均显著增加。该提取物还被证明能促进斑马鱼肠下血管(SIV)的变化,这是血管生成的一个特征。此外,通过实时PCR发现当归提取物可增强血管内皮生长因子(VEGF)mRNA的表达。在基于微珠的免疫测定中,与对照细胞相比,在渗出液中还观察到更高水平的p38和JNK 1/2表达。所有结果表明,当归提取物可促进血管生成,且血管生成作用涉及p38和JNK 1/2磷酸化。